Efficacy and Utility of Cxbladder Tests in Hematuria Patients

Active, not recruitingOBSERVATIONAL
Enrollment

684

Participants

Timeline

Start Date

November 8, 2019

Primary Completion Date

January 18, 2024

Study Completion Date

December 31, 2025

Conditions
HematuriaUrothelial Carcinoma
Interventions
DIAGNOSTIC_TEST

Cxbladder

The Cxbladder Detect test, developed by Pacific Edge Ltd (O'Sullivan 2012; Holyoake 2008; National Health Committee 2015b) is a molecular diagnostic test, which consists of five mRNA transcripts measured in a small volume of urine.

Trial Locations (10)

29401

Medical University of South Carolina, Charleston

33125

South Florida Veterans Affairs, Miami

55417

Minneapolis VA Health Care System, Minneapolis

68105

NWIHCS-Omaha VA Medical Center, Omaha

73104

Oklahoma City VA Hospital, Oklahoma City

92161

Veterans Medical Research Foundation, San Diego

33744-8200

Bay Pines Veterans Affairs, Bay Pines

33612-4745

James A Haley Veterans' Hospital, Tampa

10468-3904

James J. Peters VAMC, New York

05009

White River Junction VAMC, White River Junction

Sponsors
All Listed Sponsors
lead

Pacific Edge Limited

INDUSTRY

NCT04943380 - Efficacy and Utility of Cxbladder Tests in Hematuria Patients | Biotech Hunter | Biotech Hunter